
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland 21205-2179 [G. W. C., A. E. B., S. C. H., K. J. H.]; Biomedical Research, Our Lady of Mercy Medical Center, Bronx, New York 10466-2697 [E. P. N.]; and Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota 55454 [M. G.]
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Most of these studies have relied on histories of dietary intake or biochemical assays of serum. Dietary histories have the advantage of indicating average consumption over relatively long periods of time, but their validity suffers from the frailties of human memory and the uncertain pertinence of intake to the micronutrient concentrations in the fluids to which cells are exposed. Serum concentrations are much more likely to reflect cellular exposures, but they suffer from the fact that they are often measured at only one time and may not be representative of usual concentrations.
There are relatively few reports of intraindividual variability of
serum levels of micronutrient antioxidants such as carotenoids,
retinol, or tocopherols. Most are based on small numbers of subjects
and have relatively short intervals between assays. All are concerned
with absolute concentrations. Their findings are summarized in Table 1
.
|
Whereas it would be ideal if individual serum concentrations remained essentially the same for long periods of time, this is unlikely. Variability can arise from changes in dietary intake, metabolic changes associated with age, and diurnal and seasonal variations. In addition, if recent and past specimens are assayed at the same time, changes due to long-term storage are possible. Even if assays are performed at the time of blood collection, it is unlikely that all assay conditions will remain constant if years separate the repeat assays. However, the significance of serum micronutrients as biomarkers for future disease can still be estimated if persons who have high concentrations at one time tend to have relatively high concentrations at a later time, and if persons with low concentrations also tend to rank low in the future. It is possible that rank order correlations will be high enough for rank, grouped or individual, to be used in analyses, even if other measures of agreement are poor. Unfortunately, only in the study among Belize children could a rank order correlation be calculated: it was 0.87 for retinol (5) .
Three nested case-control studies of breast, lung, and prostate cancer in Washington County, Maryland performed repeated assays of carotenoids, retinoids, and tocopherols on serum from 260 individuals selected as normal controls (12) .4 These individuals had donated blood for a serum bank in 1974 and again in 1989. This study compares the assay results for both time periods by rank order correlation and also compares these coefficients with those for blood pressure determinations done at the times of blood donation.
| Materials and Methods |
|---|
|
|
|---|
In 1974, a brief history was first taken. After the several minutes required for this procedure, blood pressure was measured by trained nurses using a mercury sphygmomanometer with the subject seated. Diastolic pressures were defined as the point of disappearance of the Korotkov sounds. The lowest of three determinations was recorded. Finally, blood was drawn into a 15-ml vacutainer (Becton Dickinson, Rutherford, NJ), allowed to clot at room temperature for 30 min, and then refrigerated at 4°C until the serum was separated, usually within 34 h. The serum was kept at -70°C until aliquots for assays were prepared by thawing in ice water under dim yellow light. The assay specimens were shipped to the laboratory under dry ice and kept there at -70°C until assayed.
In 1989, the procedures were similar. The only major difference was that blood was collected in 20-ml vacutainers containing heparin (Becton Dickinson) and kept at 4°C until the plasma was separated 26 h later. The plasma was kept frozen at -70°C until aliquoted, shipped to the laboratory, and assayed. For the present study, specimens from CLUE I and CLUE II were aliquoted, shipped, and assayed similarly at the same time.
To study repeatability over time, assay results from previous studies were used from controls matched to the breast, lung, or prostate cancer cases who had donated blood in 1974 and again in 1989. Serum and plasma from breast and prostate cancer controls were handled similarly and assayed for carotenoids, retinoids, and tocopherols by high-performance liquid chromatography (13 , 14) . For lung cancer controls, the high-performance liquid chromatographic procedure differed slightly (15) . For the breast and prostate cancer controls, assays were performed by the Department of Biomedical Research, Our Lady of Mercy Medical Center (Bronx, NY) in 1995 and 1998, respectively; assays of specimens from lung cancer controls were performed at the Department of Epidemiology, School of Public Health, University of Minnesota (Minneapolis, MN) in 1995.
It was not appropriate to compare only the absolute concentrations of the various micronutrients in the 1974 and 1989 paired specimens. The 1974 specimens were sera, whereas the 1989 specimens were plasma; storage times were markedly different for serum and plasma; and the subjects were 15 years older in 1989 with concomitant changes in lifestyle. Because assays for the breast, lung, and prostate cancer controls were done at different times and in different laboratories, results for participants in these three studies were analyzed separately by Spearmans rank order correlation coefficients (16) . Systolic and diastolic blood pressure values were treated similarly to obtain their rank order correlation coefficients.
| Results |
|---|
|
|
|---|
|
|
Spearman rank order correlations are shown in Table 4
. For the various analytes, the mean value was 0.445 with a SD of 0.106.
Two coefficients were less than 0.30: (a)
-carotene among
lung cancer controls; and (b) retinyl palmitate among
prostate cancer controls. Two coefficients were greater than 0.60:
(a) cryptoxanthin among lung cancer controls; and
(b)
-tocopherol among prostate cancer controls. For only
two coefficients,
-carotene and lycopene among lung cancer controls,
did the 95% confidence limits include 0. For blood pressure
determinations, the mean rank order correlation coefficient was 0.46.
None of the confidence limits included 0.
|
The failure of mean blood pressure levels to increase with the aging of the study population stimulated a closer look at the data. Of the 260 participants in this study, 67 who were not taking blood pressure medication in 1974 were doing so in 1989. Their systolic and diastolic blood pressures decreased by an average of 9.4 and 9.5 mm Hg, respectively. Regression to the mean also played a part. Among persons not taking blood pressure medication at either time, those with systolic pressures over 150 mm Hg in 1974 showed an average decrease in systolic pressure of 15.4 mm Hg, whereas those with systolic pressures less than 130 mm Hg increased by only 7.2 mm. Diastolic pressures showed a similar phenomenon: readings more than 95 mm decreased by an average of 14.3 mm, whereas 1974 readings of less than 80 mm Hg were 1.6 mm higher in 1989. It is also possible that apprehension about participating in a blood donation program was less on the second experience than it had been initially and that this might have affected blood pressure levels.
| Discussion |
|---|
|
|
|---|
For a number of reasons, the micronutrient concentrations in specimens collected in 1974 and 1989 could not be expected to be the same in absolute terms. Serum was collected in 1974, and plasma was collected in 1989. However, many persons with high concentrations at one time were still in the group with high concentrations later on. For this reason, it seems reasonable to assess serum micronutrient concentrations as risk factors for disease in terms of their relative concentrations assessed by rank order correlation coefficients of assay results of specimens from the same individuals done at different times.
Although the rank order correlation coefficients for the micronutrients assayed in specimens taken in 1974 and 1989 are only moderately high (mean, 0.445; SD, 0.106), their magnitude is similar to those for the blood pressure readings at the same times (mean, 0.457; SD, 0.089). Blood pressure determinations from the 1974 project have been shown to be significantly predictive of subsequent coronary disease and increased atherosclerotic changes in the carotid arteries (17) . This study involved the 1702 Washington County residents who took part in the 1974 blood collection program and who, as participants in the Atherosclerosis Risk in Communities study, were given a thorough cardiovascular examination in the period 1987 through 1989 (18) . That examination included a history of previous cardiovascular disease and an ultrasound examination of both carotid arteries. Persons were classified as hypertensive in 1974 if their systolic blood pressures were 140 mm Hg or higher or if their diastolic blood pressures were 90 mm Hg or higher. The relative risk of having had a heart attack or coronary artery surgery between 1974 and 1989 associated with this classification of hypertension was 2.2 (95% confidence interval, 1.33.5). Similarly, among persons with no history of coronary disease or stroke before 1989, the hypertensives in 1974 had a relative risk of 2.0 (95% confidence interval, 1.42.8) of having increased subclinical atherosclerosis of the carotid arteries in 19891992.
These findings and the similarity of rank order correlation coefficients between micronutrients and blood pressure suggest that measurements of various micronutrients from a single sample can provide useful risk factors for disease processes in which they are suspected of playing a part. To confirm this possibility, future studies should report within-person variability in terms of rank order in addition to absolute values.
| Footnotes |
|---|
2 To whom requests for reprints should be
addressed. Present address: Training Center for Public Health Research,
Box 2067, Hagerstown, MD 21742-2067. ![]()
3 Unless otherwise specified, "serum" will
include both plasma and serum. ![]()
4 K. J. Helzlsouer, personal
communication. ![]()
Received 6/ 6/00; revised 10/24/00; accepted 10/31/00.
| References |
|---|
|
|
|---|
-tocopherol. Am. J. Clin. Nutr., 57: 551-556, 1993.
-tocopherol. Am. J. Clin. Nutr., 60: 106-110, 1994.
-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol. Biomark. Prev., 6: 907-916, 1997.[Abstract]
This article has been cited by other articles:
![]() |
Bibliography of Peer-Reviewed Journal Articles Am. J. Epidemiol., August 20, 2008; (2008) kwn247v1. [PDF] |
||||
![]() |
T. J Key, P. N Appleby, N. E Allen, R. C Travis, A. W Roddam, M. Jenab, L. Egevad, A. Tjonneland, N. F Johnsen, K. Overvad, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study Am. J. Clinical Nutrition, September 1, 2007; 86(3): 672 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Peters, M. F. Leitzmann, N. Chatterjee, Y. Wang, D. Albanes, E. P. Gelmann, M. D. Friesen, E. Riboli, and R. B. Hayes Serum Lycopene, Other Carotenoids, and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 962 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, S. Liu, A. D. Pradhan, J. E. Manson, J. E. Buring, J. M. Gaziano, and H. D. Sesso Plasma Lycopene, Other Carotenoids, and the Risk of Type 2 Diabetes in Women Am. J. Epidemiol., September 15, 2006; 164(6): 576 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D Sesso, J. E Buring, E. P Norkus, and J M. Gaziano Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men Am. J. Clinical Nutrition, May 1, 2005; 81(5): 990 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Sesso, J. E. Buring, S. M. Zhang, E. P. Norkus, and J. M. Gaziano Dietary and Plasma Lycopene and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1074 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Jordan, A. J. De Roos, J. B. Renner, G. Luta, A. Cohen, N. Craft, C. G. Helmick, M. C. Hochberg, and L. Arab A Case-Control Study of Serum Tocopherol Levels and the Alpha- to Gamma-Tocopherol Ratio in Radiographic Knee Osteoarthritis: The Johnston County Osteoarthritis Project Am. J. Epidemiol., May 15, 2004; 159(10): 968 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wu, J. W. Erdman Jr., S. J. Schwartz, E. A. Platz, M. Leitzmann, S. K. Clinton, V. DeGroff, W. C. Willett, and E. Giovannucci Plasma and Dietary Carotenoids, and the Risk of Prostate Cancer: A Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 260 - 269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Mayne, B. Cartmel, H. Lin, T. Zheng, and W. J. Goodwin Jr Low Plasma Lycopene Concentration is Associated with Increased Mortality in a Cohort of Patients with Prior Oral, Pharynx or Larynx Cancers J. Am. Coll. Nutr., February 1, 2004; 23(1): 34 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D Sesso, J. E Buring, E. P Norkus, and J M. Gaziano Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women Am. J. Clinical Nutrition, January 1, 2004; 79(1): 47 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sato, K. J. Helzlsouer, A. J. Alberg, S. C. Hoffman, E. P. Norkus, and G. W. Comstock Prospective Study of Carotenoids, Tocopherols, and Retinoid Concentrations and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 451 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Rock, M. D. Thornquist, M. L. Neuhouser, A. R. Kristal, D. Neumark-Sztainer, D. A. Cooper, R. E. Patterson, and L. J. Cheskin Diet and Lifestyle Correlates of Lutein in the Blood and Diet J. Nutr., March 1, 2002; 132(3): 525S - 530. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |